{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:07Z","timestamp":1787020747936,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-090"],"award-info":[{"award-number":["2022-PUMCH-B-090"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-056"],"award-info":[{"award-number":["2021-I2M-1-056"]}]},{"name":"National Natural Science Fund","award":["82271815"],"award-info":[{"award-number":["82271815"]}]},{"name":"Beijing Natural Science Foundation -Haidian Original Innovation Joint Fund","award":["L222082"],"award-info":[{"award-number":["L222082"]}]},{"name":"the National Key Research and Development Program of China","award":["No. 2016YFC0901501"],"award-info":[{"award-number":["No. 2016YFC0901501"]}]},{"name":"the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["No. 2023-JKCS-02"],"award-info":[{"award-number":["No. 2023-JKCS-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diagnosing rare diseases traditionally requires patients to endure lengthy and challenging journeys to find specialists familiar with their conditions. This study advocates a paradigm shift in rare disease diagnosis, moving from patients seeking physicians to physicians actively identifying patients. Using hereditary angioedema (HAE) as an example, we demonstrate how this approach, supported by electronic medical records (EMRs), enables proactive care for patients with rare diseases. Our EMR system incorporates a free-text search engine to screen for patients with potential HAE based on clinical symptoms and laboratory tests. Search terms include recurrent skin edema, abdominal pain, laryngeal edema, and\/or decreased C4 levels. Suspected cases are followed up by telephone calls from trained physicians, inviting patients to undergo confirmatory C1-INH and C4 testing and genetic testing to ensure accurate diagnosis and appropriate treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2,689 patients who met the screening criteria, 3,441 records were analyzed. Ninety-five patients had already been diagnosed with HAE. After excluding those with a known etiology for edema or characteristics inconsistent with HAE, three patients with unexplained cutaneous edema, abdominal pain, and\/or laryngeal edema were included in the final screening. Laboratory tests confirmed HAE in all three, highlighting the effectiveness of this proactive approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study underscores the transformative potential of EMRs in diagnosing rare diseases. By shifting the responsibility of identifying rare diseases from patients to healthcare professionals, we expedite diagnosis and exemplify the spirit of service in medicine, ensuring patients with rare diseases receive timely and effective care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03882-2","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T20:20:02Z","timestamp":1753734002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proactive identification of rare diseases: lessons from hereditary angioedema diagnosis using electronic medical records"],"prefix":"10.1186","volume":"20","author":[{"given":"Xue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-6650","authenticated-orcid":false,"given":"Yuxiang","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"2","key":"3882_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5582\/bst.2015.01048","volume":"9","author":"K Chen","year":"2015","unstructured":"Chen K, Yao L, Liu Z. Towards government-funded special biomedical research programs to combat rare diseases in China. Biosci Trends. 2015;9(2):88\u201390.","journal-title":"Biosci Trends"},{"issue":"3","key":"3882_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5582\/irdr.2018.01065","volume":"7","author":"S Derayeh","year":"2018","unstructured":"Derayeh S, Kazemi A, Rabiei R, Hosseini A, Moghaddasi H. National information system for rare diseases with an approach to data architecture: A systematic review. Intractable Rare Dis Res. 2018;7(3):156\u201363.","journal-title":"Intractable Rare Dis Res"},{"issue":"2","key":"3882_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","volume":"19","author":"M Haendel","year":"2020","unstructured":"Haendel M, Vasilevsky N, Unni D, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77\u20138.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"3882_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165\u201373.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"3882_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-021-01788-3","volume":"16","author":"X Li","year":"2021","unstructured":"Li X, Zhang X, Zhang S, et al. Rare disease awareness and perspectives of physicians in china: a questionnaire-based study. Orphanet J Rare Dis. 2021;16(1):171.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3882_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13023-017-0622-4","volume":"12","author":"Y Zurynski","year":"2017","unstructured":"Zurynski Y, Deverell M, Dalkeith T, et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12(1):68.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3882_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12016-021-08852-7","volume":"61","author":"M Gutierrez","year":"2021","unstructured":"Gutierrez M, Veronez CL, Rodrigues Valle SO, et al. Unnecessary abdominal surgeries in attacks of hereditary angioedema with normal C1 inhibitor. Clin Rev Allergy Immunol. 2021;61(1):60\u20135.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"3882_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.kint.2019.11.037","volume":"97","author":"N Garcelon","year":"2020","unstructured":"Garcelon N, Burgun A, Salomon R, Neuraz A. Electronic health records for the diagnosis of rare diseases. Kidney Int. 2020;97(4):676\u201386.","journal-title":"Kidney Int"},{"issue":"12","key":"3882_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1808012","volume":"382","author":"PJ Busse","year":"2020","unstructured":"Busse PJ, Christiansen SC. Hereditary angioedema. N Engl J Med. 2020;382(12):1136\u201348.","journal-title":"N Engl J Med"},{"key":"3882_CR10","first-page":"103","volume":"7","author":"A Ghazi","year":"2013","unstructured":"Ghazi A, Grant JA. Hereditary angioedema: epidemiology, management, and role of Icatibant. Biologics. 2013;7:103\u201313.","journal-title":"Biologics"},{"key":"3882_CR11","doi-asserted-by":"crossref","unstructured":"Santacroce R, D\u2019Andrea G, Maffione AB, Margaglione M, d\u2019Apolito M. The genetics of hereditary angioedema: A review. J Clin Med 2021;10(9).","DOI":"10.3390\/jcm10092023"},{"issue":"1","key":"3882_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","volume":"9","author":"PJ Busse","year":"2021","unstructured":"Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021;9(1):132\u2013e150133.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3882_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2147\/TCRM.S86293","volume":"12","author":"MP Henao","year":"2016","unstructured":"Henao MP, Kraschnewski JL, Kelbel T, Craig TJ. Diagnosis and screening of patients with hereditary angioedema in primary care. Ther Clin Risk Manag. 2016;12:701\u201311.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"3882_CR14","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.waojou.2021.100620","volume":"15","author":"Q Cui","year":"2022","unstructured":"Cui Q, Xu Q, Yang Y, et al. The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels. World Allergy Organ J. 2022;15(1):100620.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"3882_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1684\/ejd.2018.3487","volume":"29","author":"S Liu","year":"2019","unstructured":"Liu S, Xu Y, Liu Y, Zhi Y. Hereditary angioedema: a Chinese perspective. Eur J Dermatol. 2019;29(1):14\u201320.","journal-title":"Eur J Dermatol"},{"issue":"3","key":"3882_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","volume":"130","author":"K Bork","year":"2012","unstructured":"Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"3882_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/all.15214","volume":"77","author":"M Maurer","year":"2022","unstructured":"Maurer M, Magerl M, Betschel S, et al. The international WAO\/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022;77(7):1961\u201390.","journal-title":"Allergy"},{"key":"3882_CR18","first-page":"340","volume":"2018","author":"R Colbaugh","year":"2018","unstructured":"Colbaugh R, Glass K, Rudolf C, Tremblay. M Volv Global Lausanne Switzerland 2018 Learning to identify rare disease patients from electronic health records. AMIA Annu Symp Proc 2018 340\u20137.","journal-title":"AMIA Annu Symp Proc"},{"issue":"2","key":"3882_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2500\/aap.2021.42.210001","volume":"42","author":"Y Cao","year":"2021","unstructured":"Cao Y, Liu S, Zhi Y. Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema. Allergy Asthma Proc. 2021;42(2):131\u20135.","journal-title":"Allergy Asthma Proc"},{"key":"3882_CR20","first-page":"1","volume":"98","author":"E Jamoom","year":"2012","unstructured":"Jamoom E, Beatty P, Bercovitz A, Woodwell D, Palso K, Rechtsteiner E. Physician adoption of electronic health record systems: united states, 2011. NCHS Data Brief. 2012;98:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"23","key":"3882_CR21","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1001\/jama.2012.4946","volume":"307","author":"E Toll","year":"2012","unstructured":"Toll E. A piece of my mind. The cost of technology. JAMA. 2012;307(23):2497\u20138.","journal-title":"JAMA"},{"issue":"11","key":"3882_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/M16-0961","volume":"165","author":"C Sinsky","year":"2016","unstructured":"Sinsky C, Colligan L, Li L, et al. Allocation of physician time in ambulatory practice: A time and motion study in 4 specialties. Ann Intern Med. 2016;165(11):753\u201360.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3882_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ajhg.2017.01.006","volume":"100","author":"RB Ramoni","year":"2017","unstructured":"Ramoni RB, Mulvihill JJ, Adams DR, et al. The undiagnosed diseases network: accelerating discovery about health and disease. Am J Hum Genet. 2017;100(2):185\u201392.","journal-title":"Am J Hum Genet"},{"issue":"19","key":"3882_CR24","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJMp1108726","volume":"365","author":"J Frankovich","year":"2011","unstructured":"Frankovich J, Longhurst CA, Sutherland SM. Evidence-based medicine in the EMR era. N Engl J Med. 2011;365(19):1758\u20139.","journal-title":"N Engl J Med"},{"issue":"D1","key":"3882_CR25","doi-asserted-by":"publisher","first-page":"D1018","DOI":"10.1093\/nar\/gky1105","volume":"47","author":"S Kohler","year":"2019","unstructured":"Kohler S, Carmody L, Vasilevsky N, et al. Expansion of the human phenotype ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47(D1):D1018\u201327.","journal-title":"Nucleic Acids Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03882-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:41:11Z","timestamp":1757310071000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03882-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3882"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03882-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent under a research protocol approved by the Research Ethical Committee of the Peking Union Medical College Hospital (Approval number: K3640). Additionally, all participants gave consent for the publication of their data. No previously published graphic or tabular material has been used in this manuscript..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the final version of the manuscript and provided written agreement for its publication in\n                      Orphanet Journal of Rare Diseases\n                      as an open-access article. Additionally, all participants provided informed consent for the publication of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our manuscript is original, has not been published before, is not currently being considered for publication elsewhere, and has not been posted to a preprint server.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Confirmation of unpublished work"}}],"article-number":"386"}}